D. V. Teffenberg
Research Subjects
D. V. Teffenberg has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
A. A. Sadchikov
Medical Center Avicenna
2 shared publications- Aleksandr N. Kokov
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, 6, boulevard named after academician L.S. Barbarasha, Kemerovo 650002, Russia
2 shared publications - Aleksei A. Ansheles
Department of Myocardial Diseases and Heart Failure, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia
2 shared publications - Andrew V. Mochula
Cardiology Research Institute, Tomsk National Research Medical Center
2 shared publications - Daria V. Ryzhkova
Federal State Budgetary Institution “Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
2 shared publications - E. A. Drizner
Sverdlovsk Regional Oncology Dispensary
2 shared publications
Latest Publications
- Open Access
- 2 July 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (3) , 357-366
Early identification of cardiac ATTR amyloidosis: a clinical case
Progress in instrumental diagnostics, as well as increased awareness among doctors about rare diseases, is steadily leading to an increased number of patients diagnosed with cardiac amyloidosis. Regardless of amyloid formation route, cardiac damage is the main cause of mortality in systemic amyloidosis. The article presents a unique clinical observation of hereditary transthyretin (ATTR) amyloidosis mixed phenotype detection during skeletal scintigraphy. In the patient with severe shortness of breath, based on the results of radiological research, an oncological process in the lungs was suspected. The patient underwent skeletal scintigraphy to exclude metastatic lesions, during which a scintigraphy pattern characteristic of ATTR amyloidosis (Grade 3) was revealed. Subsequently, the oncological diagnosis was removed. An independent disease of hematopoietic system was excluded, and mutation in TTR gene was additionally confirmed. This clinical case illustrates the possibility of making a diagnosis of cardiac amyloidosis without resorting to myocardial biopsy, when the patient still has slight limitations in physical activity (NYHA class II) and there is no late gadolinium enhancement on magnetic resonance imaging.
- 2 July 2024
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 20 (3) , 357-366
Open AccessEarly identification of cardiac ATTR amyloidosis: a clinical case
Progress in instrumental diagnostics, as well as increased awareness among doctors about rare diseases, is steadily leading to an increased number of patients diagnosed with cardiac amyloidosis. Regardless of amyloid formation route, cardiac damage is the main cause of mortality in systemic amyloidosis. The article presents a unique clinical observation of hereditary transthyretin (ATTR) amyloidosis mixed phenotype detection during skeletal scintigraphy. In the patient with severe shortness of breath, based on the results of radiological research, an oncological process in the lungs was suspected. The patient underwent skeletal scintigraphy to exclude metastatic lesions, during which a scintigraphy pattern characteristic of ATTR amyloidosis (Grade 3) was revealed. Subsequently, the oncological diagnosis was removed. An independent disease of hematopoietic system was excluded, and mutation in TTR gene was additionally confirmed. This clinical case illustrates the possibility of making a diagnosis of cardiac amyloidosis without resorting to myocardial biopsy, when the patient still has slight limitations in physical activity (NYHA class II) and there is no late gadolinium enhancement on magnetic resonance imaging.
- Open Access
- 4 January 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (12) , 5134
Current status of nuclear cardiology in the Russian Federation
The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.
- 4 January 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (12) , 5134
Open AccessCurrent status of nuclear cardiology in the Russian Federation
The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.
- Open Access
- 4 January 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (12) , 5134
Current status of nuclear cardiology in the Russian Federation
The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.
- 4 January 2023
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (12) , 5134
Open AccessCurrent status of nuclear cardiology in the Russian Federation
The article is devoted to the analysis of the current status of nuclear cardiology in the Russian Federation. The data on the number of facilities performing radionuclide investigations for the diagnosis and monitoring of the treatment of cardiovascular diseases, their staffing and equipment are given. The statistics of the conducted nuclear cardiology tests for 2018-2020 are given, as well as their methods, features and diagnostic significance are described.